Published Date: 31-07-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Dialyzer Market, published by KBV research, the LAMEA Dialyzer Market would witness market growth of 7.27% CAGR during the forecast period (2019-2025).
The Brazil market dominated the LAMEA Home Dialysis Market by Country in 2018, growing at a CAGR of 3.9 % during the forecast period. The Argentina market is expected to witness a CAGR of 6% during (2019-2025). Additionally, The UAE market is expected to witness a CAGR of 5.4% during (2019-2025).
The High-Flux Dialyzer market dominated the LAMEA Dialyzer Market by Type in 2018, growing at a CAGR of 7.7 % during the forecast period. The Low-Flux Dialyzer market is expected to witness a CAGR of 6.5% during (2019-2025).
The In-Center Dialysis market dominated the UAE Dialyzer Market by End User in 2018, thereby, achieving a market value of $48.9 million by 2025, growing at a CAGR of 7 % during the forecast period. The Home Dialysis market is expected to witness a CAGR of 5.4% during (2019-2025).
Full Report: https://www.kbvresearch.com/lamea-dialyzer-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Baxter International, Inc., CVS Health Corporation, Fresenius Medical Care AG & Co. KGaA, DaVita, Inc., Asahi Kasei Corporation, Cardinal Health, Inc., Cantel Medical Corporation, Nipro Corporation, Allmed Medical Care Holdings Limited and Terumo Corporation.
By End User
Unique Offerings from KBV Research